Contents

CNS & Neurological Disorders - Drug Targets , Volume 10 - Number 2

Commentary (Research Highlights)

, 10(2): 146

Prabhakara V. Choudary


DOI: 10.2174/187152711794480465




Editorial [Hot Topic: Oxidative Stress Induced-Metabolic Imbalance, Mitochondrial Failure, And Cellular Hypoperfusion As Primary Pathogenetic Factors For The Development Of Alzheimer Disease Which Can Be Used As An Alternate And Successful Drug Treatment Strategy: Past, Present And Future (Guest Editor: Gjumrakch Aliev)]

, 10(2): 147 - 148

Gjumrakch Aliev


DOI: 10.2174/187152711794480492




Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease

, 10(2): 149 - 162

Hector H. Palacios, Bharat B. Yendluri, Kalpana Parvathaneni, Vagif B. Shadlinski, Mark E. Obrenovich, Jerzy Leszek, Dmitry Gokhman, Kazimierz Gasiorowski, Valentin Bragin and Gjumrakch Aliev


DOI: 10.2174/187152711794480474




Alzheimers Disease: From Pathogenesis to Disease-Modifying Approaches

, 10(2): 163 - 174

Daniela Galimberti and Elio Scarpini


DOI: 10.2174/187152711794480438




Implication of Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegenerative Disorders – Contemporary Approaches

, 10(2): 175 - 183

Adrian Sieradzki, Bharat B. Yendluri, Hector H. Palacios, Kalpana Parvathaneni, V. Prakash Reddy, Mark E. Obrenovich, Kazimierz Gasiorowski, Jerzy Leszek and Gjumrakch Aliev


DOI: 10.2174/187152711794480410




Flavones from Root of Scutellaria Baicalensis Georgi: Drugs of the Future in Neurodegeneration?

, 10(2): 184 - 191

Kazimierz Gasiorowski, Eliza Lamer-Zarawska, Jerzy Leszek, Kalpana Parvathaneni, Bharat Bhushan Yendluri, Zofia Blach-Olszewska and Gjumrakch Aliev


DOI: 10.2174/187152711794480384




Antioxidants in Health, Disease and Aging

, 10(2): 192 - 207

Mark E. Obrenovich, Yi Li, Kalpana Parvathaneni, Bharat B. Yendluri, Hector H. Palacios, Jerzy Leszek and Gjumrakch Aliev


DOI: 10.2174/187152711794480375




Overcoming Cell Death and Tau Phosphorylation Mediated by PI3KInhibition: A Cell Assay to Measure Neuroprotection

, 10(2): 208 - 214

D. Simon, M. Medina, J. Avila and F. Wandosell


DOI: 10.2174/187152711794480401




Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke

, 10(2): 215 - 234

P. S. Manoonkitiwongsa


DOI: 10.2174/187152711794480447




Targeting Hypoxia Inducible Factor-1α: A Novel Mechanism of Ginsenoside Rg1 for Brain Repair after Hypoxia/Ischemia Brain Damage

, 10(2): 235 - 238

Binzhi Tang, Yi Qu, Dejian Wang and Dezhi Mu


DOI: 10.2174/187152711794480456




The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinsons Disease

, 10(2): 239 - 250

Helineide Cristina Campos, Miguel Divino da Rocha, Flavia Pereira Dias Viegas, Patricia Carolina Nicastro, Poliana Calve Fossaluzza, Carlos Alberto Manssour Fraga, Eliezer J. Barreiro and Claudio Viegas


DOI: 10.2174/187152711794480483




The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease

, 10(2): 251 - 270

Miguel Divino da Rocha, Flavia Pereira Dias Viegas, Helineide Cristina Campos, Patricia Carolina Nicastro, Poliana Calve Fossaluzza, Carlos Alberto Manssour Fraga, Eliezer J. Barreiro and Claudio Viegas


DOI: 10.2174/187152711794480429




The Urokinase Receptor in the Central Nervous System

, 10(2): 271 - 294

Marco Archinti, Mishan Britto, Gabriele Eden, Federico Furlan, Ronan Murphy and Bernard Degryse


DOI: 10.2174/187152711794480393




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science